Vice President, Early-Stage Clinical Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alto Neuroscience · 1 month ago

Vice President, Early-Stage Clinical Development

positionMountain View, CA
timeFull-time
remoteHybrid
seniorityDirector/Executive
money$285K/yr - $305K/yr
date10+ years exp

Alto Neuroscience is seeking a dynamic and experienced leader to serve as Vice President, Early-Stage Clinical Development. This role will lead the strategy and execution of early development activities across Alto’s portfolio, ensuring that each program advances efficiently and compliantly.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
check
H1B Sponsor Likelynote

Responsibilities

Lead integrated early development strategy and execution for all pipeline assets
Design and oversee IND-enabling and early clinical studies
Partner cross-functionally to align development, regulatory, and operational plans
Manage CRO and vendor relationships for quality, speed, and cost efficiency
Build and mentor a growing early development team
Represent Alto with regulators, advisors, and external collaborators
Ensure compliance with applicable regulations, guidelines, and standards (e.g., GxP, ICH, FDA/EMA expectations) as well as Alto’s internal quality systems and SOPs

Qualification

Drug developmentIND-enabling studiesToxicology expertiseClinical pharmacologyTranslational scienceLeadership skillsCommunication skillsCollaboration skills

Required

Advanced Degree (MD, PhD, or PharmD) with 10+ years in drug development
Proven success leading IND-enabling and early-phase studies in biotech or pharma
Deep expertise in toxicology, clinical pharmacology, and translational science
Strong leadership, communication, and cross-functional collaboration skills
Thrives in a dynamic, fast-paced, mission-driven environment

Benefits

Compensation includes a base salary, an annual target bonus, and an equity grant.

Company

Alto Neuroscience

twittertwittertwitter
company-logo
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
dateFounded in 2019
location
Los Altos, California, USA
people-size51-200 employees
web-link
https://www.altoneuroscience.com

H1B Sponsorship

Alto Neuroscience has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (2)
2022 (4)
2021 (2)

Funding

Current Stage
Public Company
Total Funding
$300.96M
Key Investors
Perceptive AdvisorsWellcome TrustInVivium Capital
2025-10-20Post Ipo Equity· $50M
2024-07-25Grant· $11.7M
2024-02-02IPO

Leadership Team

leader-logo
Amit Etkin
Founder and CEO
linkedin
leader-logo
Wei Wu
Co-Founder
linkedin

Recent News

Benzinga.com
FDA Lifts Hold On GH Research's Depression Drug Trial After Two Years
2026-01-05
BioSpace
5 Depression Trials That Failed in 2025
2025-12-08
Johnson Fistel, PLLP
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Dow Inc. (DOW), and Fly-E Group, Inc. (FLYE)
2025-12-02
Company data provided by crunchbase